NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,963.26 mln
Float39.76 mln
Earnings Date11/11/2026
EPS
0.48
Overpriced
P / E
79.88
Speculative
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.69
Likely reliable
1-Year Forecast
60.57
Exceptional upside
Relative Strength
21
/ 100
Significantly lagging
Business Description
Vericel Corporation, based in Cambridge, Massachusetts, develops and sells specialized medical treatments using living cells and biological materials. The company offers three main products: a knee cartilage repair treatment, a permanent skin replacement for severe burn patients, and a burn wound cleaning therapy used in both adults and children. Originally founded in 1989 under the name Aastrom Biosciences, Vericel serves healthcare providers across North America in the fields of sports medicine and burn care.
